Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MYF-01-37 (1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one) 是共价TEAD 抑制剂,靶向 Cys380,能够可逆地抑制 YAP/TEAD 相互作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 293 | 现货 | ||
5 mg | ¥ 475 | 现货 | ||
10 mg | ¥ 725 | 现货 | ||
25 mg | ¥ 1,470 | 现货 | ||
50 mg | ¥ 2,190 | 现货 | ||
100 mg | ¥ 3,270 | 现货 | ||
500 mg | ¥ 7,180 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 463 | 现货 |
产品描述 | MYF-01-37 (1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one) is a novel covalent TEAD inhibitor. |
体外活性 | Pretreating cells with MYF-01–37 led to loss of direct TEAD pull-down by biotin-MYF-01–037 ?from whole-cell lysate, confirming MYF-01–037 binding to TEAD in cells.?This target engagement of TEAD resulted in inhibition of direct YAP/TEAD interaction in HEK 293T cells, and in the reduction in canonical YAP target gene CTGF expression in PC-9 cells.?This reduction was abrogated by the overexpression of TEAD1 C359S mutant that disrupts the covalent binding of the drug to TEAD, but not by overexpression of wild-type TEAD1, demonstrating that the observed inhibition of YAP activity is due to on-target covalent binding of the compound to TEAD. |
别名 | 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one |
分子量 | 298.3 |
分子式 | C15H17F3N2O |
CAS No. | 2416417-65-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (184.38 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.3523 mL | 16.7616 mL | 33.5233 mL | 83.8082 mL |
5 mM | 0.6705 mL | 3.3523 mL | 6.7047 mL | 16.7616 mL | |
10 mM | 0.3352 mL | 1.6762 mL | 3.3523 mL | 8.3808 mL | |
20 mM | 0.1676 mL | 0.8381 mL | 1.6762 mL | 4.1904 mL | |
50 mM | 0.067 mL | 0.3352 mL | 0.6705 mL | 1.6762 mL | |
100 mM | 0.0335 mL | 0.1676 mL | 0.3352 mL | 0.8381 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MYF-01-37 2416417-65-5 Others Stem Cells YAP Cys380 MYF 01 37 inhibit Inhibitor MYF0137 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one YAP/TEAD Yes-associated protein HEK293T inhibitor